Emmaus Life Sciences Incorporation – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late annual filing notification for FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Registration of securities for employees

Exempt offering of securities

Ownership Filter

Zwicker Ian Harvey

Stark Charles William

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Reports Q3 2023 Financial Results

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Reports Management Changes

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC